Larissa Hering
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Corrigendum to Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Journal: The Journal of clinical investigation
Published: April 01, 2026
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: December 31, 2021
Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis.
Journal: International journal of molecular sciences
Published: May 18, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors.
Journal: Cell host & microbe
Published: March 08, 2021
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Journal: The Journal of clinical investigation
Published: May 14, 2020
Activation of pH-Sensing Receptor OGR1 (GPR68) Induces ER Stress Via the IRE1α/JNK Pathway in an Intestinal Epithelial Cell Model.
Journal: Scientific reports
Published: April 09, 2019
Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23.
Journal: Inflammatory intestinal diseases
Published: September 20, 2018
Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner.
Journal: The Journal of clinical investigation
Published: June 28, 2018
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.
Journal: Mucosal immunology
Published: January 25, 2018
Last Updated: 09/26/2026